PMID- 11300507 OWN - NLM STAT- MEDLINE DCOM- 20010621 LR - 20190513 IS - 0146-4760 (Print) IS - 0146-4760 (Linking) VI - 25 IP - 2 DP - 2001 Mar TI - Sweat testing of MDMA with the Drugwipe analytical device: a controlled study with two volunteers. PG - 144-6 AB - Rapid on-site tests for the analysis of drugs of abuse in unconventional specimens (e.g., sweat) have recently been developed. Two healthy volunteers familiar with the effects of methylenedioxymethamphetamine (MDMA) were given 100 mg of the drug as a single oral dose. MDMA and its main metabolite 4-hydroxy-3-methoxymethamphetamine (HMMA) were determined in plasma and urine by gas chromatography-mass spectrometry (GC-MS). MDMA was also investigated in sweat with the Drugwipe (an immunochemical strip test). Subjects' armpits were swabbed for 10 s at 0 time (predose) and at 2, 6, 8, 12, and 24 h after MDMA administration. MDMA consumption could be detected using Drugwipe at 2 h and for as long as 12 h after drug administration. However, in one of the volunteers, a faint color change appeared at 0 time, when plasma and urine tested negative for MDMA and did not disappear even 48 h later. Plasma concentrations of MDMA and HMMA measured by GC-MS peaked at 2-4 h, and values greater than 20 ng/mL for MDMA and of 40 ng/mL for HMMA were still detected at 24 h. Urine tested positive by GC-MS for MDMA and HMMA in the 48-h collection period. These findings preliminarily support sweat testing with Drugwipe for monitoring MDMA use. FAU - Pacifici, R AU - Pacifici R AD - Istituto Superiore di Sanita, Roma, Italy. FAU - Farre, M AU - Farre M FAU - Pichini, S AU - Pichini S FAU - Ortuno, J AU - Ortuno J FAU - Roset, P N AU - Roset PN FAU - Zuccaro, P AU - Zuccaro P FAU - Segura, J AU - Segura J FAU - de la Torre, R AU - de la Torre R LA - eng PT - Clinical Trial PT - Controlled Clinical Trial PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Anal Toxicol JT - Journal of analytical toxicology JID - 7705085 RN - 0 (Lactates) RN - 0 (Reagent Strips) RN - 515-30-0 (atrolactic acid) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Humans MH - Immunochemistry/methods MH - Lactates/analysis MH - Male MH - N-Methyl-3,4-methylenedioxyamphetamine/*analysis/pharmacokinetics MH - *Reagent Strips MH - Substance Abuse Detection/instrumentation/*methods MH - Sweat/*chemistry MH - Time Factors EDAT- 2001/04/13 10:00 MHDA- 2001/06/22 10:01 CRDT- 2001/04/13 10:00 PHST- 2001/04/13 10:00 [pubmed] PHST- 2001/06/22 10:01 [medline] PHST- 2001/04/13 10:00 [entrez] AID - 10.1093/jat/25.2.144 [doi] PST - ppublish SO - J Anal Toxicol. 2001 Mar;25(2):144-6. doi: 10.1093/jat/25.2.144.